XCUR (Exicure, Inc. Common Stock) Stock Analysis - SEC Filings

Exicure, Inc. Common Stock (XCUR) is a publicly traded Healthcare sector company. As of May 21, 2026, XCUR trades at $2.76 with a market cap of $19.50M and a P/E ratio of -3.70. XCUR moved +2.08% today. Year to date, XCUR is -46.89%; over the trailing twelve months it is -70.69%. Its 52-week range spans $2.15 to $36.00. Rallies surfaces XCUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find XCUR SEC filings?

Rallies organizes XCUR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

XCUR Key Metrics

Key financial metrics for XCUR
MetricValue
Price$2.76
Market Cap$19.50M
P/E Ratio-3.70
EPS$-0.79
Dividend Yield0.00%
52-Week High$36.00
52-Week Low$2.15
Volume2
Avg Volume0
Revenue (TTM)$0
Net Income$-4.95M
Gross Margin0.00%

Latest XCUR News

Recent XCUR Insider Trades

  • Exicure HiTron Inc. sold 258.37K (~$1.16M) on Jan 21, 2026.
  • Exicure HiTron Inc. sold 734.75K (~$3.31M) on Jan 16, 2026.
  • Exicure HiTron Inc. sold 741.27K (~$3.34M) on Jan 7, 2026.

XCUR Analyst Consensus

XCUR analyst coverage data. Average price target: $0.00.

Common questions about XCUR

Where can I find XCUR SEC filings?
Rallies organizes XCUR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show XCUR 10-K and 10-Q filings?
Rallies organizes XCUR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is XCUR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XCUR. It does not provide personalized investment advice.
XCUR

XCUR